This inventor holds 2 USPTO granted patents. Top assignee: Centessa Pharmaceuticals (UK) Limited. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Wojciech Zawodny: Innovator in Orexin Receptor Modulation
Introduction
Wojciech Zawodny is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that modulate orexin receptor activity. His work is crucial for addressing various disorders linked to orexin receptors.
Latest Patents
Wojciech Zawodny holds a patent for "Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists." This patent describes compounds of Formula (I′) and their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed are useful for modulating orexin receptor activity and may be employed in the treatment of disorders such as narcolepsy, hypersomnia, neurodegenerative disorders, mental health disorders, metabolic syndrome, osteoporosis, cardiac failure, coma, and complications in emergence from anesthesia.
Career Highlights
Wojciech Zawodny is currently associated with Centessa Pharmaceuticals (UK) Limited, where he continues to advance his research and development efforts. His innovative approach has positioned him as a key figure in the pharmaceutical industry, particularly in the realm of orexin receptor modulation.
Collaborations
Wojciech has collaborated with notable colleagues, including Matthew Spendiff and Bruce Lefker. These partnerships have enhanced his research capabilities and contributed to the success of his projects.
Conclusion
Wojciech Zawodny's work in the field of orexin receptor modulation represents a significant advancement in pharmacological research. His contributions are vital for the development of treatments for various disorders, showcasing the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile